Literature DB >> 22593549

Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Traci A Czyzyk1, Amparo Romero-Picó, John Pintar, Jaime H McKinzie, Matthias H Tschöp, Michael A Statnick, Ruben Nogueiras.   

Abstract

Pharmacological manipulation of opioid receptors alters feeding behavior. However, the individual contributions of each opioid receptor subtype on energy balance remain largely unknown. Herein, we investigated whether genetic disruption of the δ-opioid receptor (DOR) also controls energy homeostasis. Mice lacking DOR and wild-type mice were fed with standard diet and high-energy diet (HED). Mice were analyzed in vivo with the indirect calorimetry system, and tissues were analyzed by real-time PCR and Western blot analysis. DOR-knockout (KO) mice gained less weight (P<0.01) and had lower fat mass (P<0.01) when compared to WT mice fed an HED. Although DOR-KO mice were hyperphagic, they showed higher energy expenditure (P<0.05), which was the result of an increased activation of the thermogenic program in brown adipose tissue. The increased nonshivering thermogenesis involved the stimulation of uncoupling protein 1 (UCP1; P<0.01), peroxisome proliferator-activated receptor γ coactivator (PGC1α; P<0.05), and fibroblast growth factor 21 (FGF21; P<0.01). DOR deficiency also led to an attenuation of triglyceride content in the liver (P<0.05) in response to an HED. These findings reveal a novel role of DOR in the control of thermogenic markers and energy expenditure, and they provide a potential new therapeutic approach for the treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593549      PMCID: PMC3405260          DOI: 10.1096/fj.12-208041

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

Review 1.  Towards a molecular understanding of adaptive thermogenesis.

Authors:  B B Lowell; B M Spiegelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  Opioid peptides and the control of human ingestive behaviour.

Authors:  Martin R Yeomans; Richard W Gray
Journal:  Neurosci Biobehav Rev       Date:  2002-10       Impact factor: 8.989

3.  Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.

Authors:  D Filliol; S Ghozland; J Chluba; M Martin; H W Matthes; F Simonin; K Befort; C Gavériaux-Ruff; A Dierich; M LeMeur; O Valverde; R Maldonado; B L Kieffer
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

4.  Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Authors:  Aamir R Zuberi; Leigh Townsend; Laurel Patterson; Huiyuan Zheng; Hans-Rudi Berthoud
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

Review 5.  Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism.

Authors:  Christophe Handschin; Bruce M Spiegelman
Journal:  Endocr Rev       Date:  2006-10-03       Impact factor: 19.871

6.  Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice.

Authors:  A A Evans; G Tunnicliffe; P Knights; C J Bailey; M E Smith
Journal:  Metabolism       Date:  2001-12       Impact factor: 8.694

7.  Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice.

Authors:  Y Zhu; M A King; A G Schuller; J F Nitsche; M Reidl; R P Elde; E Unterwald; G W Pasternak; J E Pintar
Journal:  Neuron       Date:  1999-09       Impact factor: 17.173

8.  Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

Authors:  Claire Gaveriaux-Ruff; Chihiro Nozaki; Xavier Nadal; Xavier C Hever; Raphael Weibel; Audrey Matifas; David Reiss; Dominique Filliol; Mohammed A Nassar; John N Wood; Rafael Maldonado; Brigitte L Kieffer
Journal:  Pain       Date:  2011-02-03       Impact factor: 6.961

9.  Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

Authors:  Allison E Sahr; Dana K Sindelar; Jesline T Alexander-Chacko; Brian J Eastwood; Charles H Mitch; Michael A Statnick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-04       Impact factor: 3.619

10.  Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.

Authors:  S Brugman; D J Clegg; S C Woods; R J Seeley
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

View more
  25 in total

Review 1.  Brown and beige fat: development, function and therapeutic potential.

Authors:  Matthew Harms; Patrick Seale
Journal:  Nat Med       Date:  2013-09-29       Impact factor: 53.440

Review 2.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

3.  Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin.

Authors:  Amparo Romero-Picó; Maria J Vázquez; David González-Touceda; Cintia Folgueira; Karolina P Skibicka; Mayte Alvarez-Crespo; Margriet A Van Gestel; Douglas A Velásquez; Christoph Schwarzer; Herbert Herzog; Miguel López; Roger A Adan; Suzanne L Dickson; Carlos Diéguez; Rubén Nogueiras
Journal:  Neuropsychopharmacology       Date:  2013-01-24       Impact factor: 7.853

Review 4.  Adaptive thermogenesis in adipocytes: is beige the new brown?

Authors:  Jun Wu; Paul Cohen; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

5.  Genetics and Epigenetics of Eating Disorders.

Authors:  Zeynep Yilmaz; J Andrew Hardaway; Cynthia M Bulik
Journal:  Adv Genomics Genet       Date:  2015-03-10

Review 6.  Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.

Authors:  Madeline M Corrao; Leigh Anne Nelson
Journal:  CNS Drugs       Date:  2022-05-30       Impact factor: 6.497

Review 7.  Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.

Authors:  Bal Krishan Sharma; Mallikarjun Patil; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

8.  Involvement of Endogenous Enkephalins and β-Endorphin in Feeding and Diet-Induced Obesity.

Authors:  Ian A Mendez; Sean B Ostlund; Nigel T Maidment; Niall P Murphy
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

9.  Hypothalamic dopamine signaling regulates brown fat thermogenesis.

Authors:  Cintia Folgueira; Daniel Beiroa; Begoña Porteiro; Manon Duquenne; Emma Puighermanal; Marcos F Fondevila; Silvia Barja-Fernández; Rosalia Gallego; René Hernández-Bautista; Cecilia Castelao; Ana Senra; Patricia Seoane; Noemi Gómez; Pablo Aguiar; Diana Guallar; Miguel Fidalgo; Amparo Romero-Pico; Roger Adan; Clemence Blouet; Jose Luís Labandeira-García; Françoise Jeanrenaud; Imre Kallo; Zsolt Liposits; Javier Salvador; Vincent Prevot; Carlos Dieguez; Miguel Lopez; Emmanuel Valjent; Gema Frühbeck; Luisa M Seoane; Ruben Nogueiras
Journal:  Nat Metab       Date:  2019-08-19

10.  Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance.

Authors:  Marc Schneeberger; Marcelo O Dietrich; David Sebastián; Mónica Imbernón; Carlos Castaño; Ainhoa Garcia; Yaiza Esteban; Alba Gonzalez-Franquesa; Ignacio Castrillón Rodríguez; Analía Bortolozzi; Pablo M Garcia-Roves; Ramon Gomis; Ruben Nogueiras; Tamas L Horvath; Antonio Zorzano; Marc Claret
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.